Inventor
MARKS PHILIP
GB29 patents
⚠️ This page may combine multiple inventors who share the name “MARKS PHILIP”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SYNTAXIN LTD
8 patentsUS7659092B2Feb 9, 2010
Fusion proteins
SYNTAXIN LTD58 citations98
US7452543B2Nov 18, 2008
Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics
SYNTAXIN LTD49 citations95
US7897158B2Mar 1, 2011
Recombinant toxin fragments
SYNTAXIN LTD11 citations92
US8940870B2Jan 27, 2015
Fusion proteins
SYNTAXIN LTD11 citations84
US8372615B2Feb 12, 2013
Fusion proteins
SYNTAXIN LTD7 citations83
US8017134B2Sep 13, 2011
Recombinant toxin fragments
SYNTAXIN LTD5 citations73
US8012491B2Sep 6, 2011
Recombinant toxin fragments
SYNTAXIN LTD6 citations62
US8956847B2Feb 17, 2015
Fusion proteins
SYNTAXIN LTD3 citations61
FOSTER KEITH
5 patentsUS8067200B2Nov 29, 2011
Fusion proteins
FOSTER KEITH43 citations97
US8399401B2Mar 19, 2013
Fusion proteins
FOSTER KEITH18 citations92
US9243301B2Jan 26, 2016
Fusion proteins
FOSTER KEITH15 citations84
US9072736B2Jul 7, 2015
Treatment of pain
FOSTER KEITH8 citations84
US8399400B2Mar 19, 2013
Fusion proteins
FOSTER KEITH13 citations84
HEALTH PROT AGENCY
3 patentsIPSEN BIOINNOVATION LTD
3 patentsUS10030238B2Jul 24, 2018
Recombinant clostridium botulinum neurotoxins
IPSEN BIOINNOVATION LTD8 citations78
US10113159B2Oct 30, 2018
Suppression of cancer
IPSEN BIOINNOVATION LTD2 citations67
US10550377B2Feb 4, 2020
Suppression of prostate cancer using a targeted clostridial neurotoxin
IPSEN BIOINNOVATION LTD0 citations46